CNS pipeline · person
Matthew C. Abernethy
Chief Financial Officer of Neurocrine Biosciences since November 2017, responsible for corporate finance, information technology, investor relations, and facilities. He previously held finance and investor relations roles at Zimmer Biomet and began his career at KPMG.
- 1 company
Courtesy Neurocrine Biosciences
Current roles
- Neurocrine Biosciences, Inc.Chief Financial Officer · Executive
Appears with
People sharing a company with Matthew.
- Andrew Ratz · Neurocrine Biosciences, Inc.
- Christine A. Poon · Neurocrine Biosciences, Inc.
- Darin M. Lippoldt · Neurocrine Biosciences, Inc.
- David W. Boyer · Neurocrine Biosciences, Inc.
- Eric Benevich · Neurocrine Biosciences, Inc.
- Gary A. Lyons · Neurocrine Biosciences, Inc.
- George J. Morrow · Neurocrine Biosciences, Inc.
- Ingrid Delaet · Neurocrine Biosciences, Inc.
- Johanna Mercier · Neurocrine Biosciences, Inc.
- Jude Onyia · Neurocrine Biosciences, Inc.
- Julie S. Cooke · Neurocrine Biosciences, Inc.
- Kevin C. Gorman · Neurocrine Biosciences, Inc.
- Kyle W. Gano · Neurocrine Biosciences, Inc.
- Leslie V. Norwalk · Neurocrine Biosciences, Inc.
- Richard F. Pops · Neurocrine Biosciences, Inc.
- Sanjay Keswani · Neurocrine Biosciences, Inc.
- Shalini Sharp · Neurocrine Biosciences, Inc.
- Stephen A. Sherwin · Neurocrine Biosciences, Inc.
- William H. Rastetter · Neurocrine Biosciences, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.